Clinical Trials on Burns Deep Second Degree in Hong Kong
Total 1 results
-
Queen Mary Hospital, Hong KongRecruitingQuality of Life | Burns | Self Efficacy | Burn Injury | Adherence, Treatment | Burn Second Degree | Burns Third DegreeChina
Sponsors and Collaborators
- Secretariat of Public Education (SEP)
- Tarek Alsaied
- Amira Hussin Hussin Mohammed
- Holger Dressel
- Camille Levy
- Craving Change
- Healthy Life
- Innovative Therapies, Inc.
- First People's Hospital of Shenyang
- Azienda Unità Sanitaria Locale Reggio Emilia
- Ringerike sykehus, Vestre Viken HF
- Institute of Cancer Research (ICR), United Kingdom
- Monroe Carell Jr. Children's Hospital at Vanderbilt
- Ozden Gokcek
- Facultad de Estudios Superiores Aragón UNAM
- Giovanni Mirabella
- Clinical Oncology department. Elmansoura University.
- Jorge Orduña-Valls
- Colorado Childrens Hospital
- CellMaxLife
- View Full List
Medical Conditions
- Rectal Adenocarcinoma
- Skin and Subcutaneous Tissue Infection
- Postoperative Analgesic Demand
- Ascorbic Acid
- Human Herpes Virus-6 Infection
- Angiotensin-Converting Enzyme Inhibitors
- Asthma, Allergic
- Peripheral Neuropathy Associated With Anti-myelin Associated Glycoprotein Antibodies (Anti-MAG Neuropathy)
- Post-operative Intercostal Neuralgia
- Drainage Procedure
- Impulse-Control Disorders
- Acute Myelogenous Leukemia (AML or ANLL)
- Ventilator Induced Diaphragm Dysfunction
- Homologous Recombination Deficient Solid Tumors
- CYP2C19 Poor
- MINI MENTAL STATE EXAMINATION TEST
- Emergency Geriatric Care
- Body Height
- Triple Negative Breast Cancer, TNBC
- Established Atherosclerotic Cardiovascular Disease (ASCVD) or ASCVD Risk
- View Full List
Drug Interventions
- Xenon
- Standard of care
- Ascorbic Acid
- RBS2418
- Topical Solution
- GW-1000-02
- Prolonged release (PR) OROS methylphenidate 72 mg
- Tenecteplase
- AMT-101 (oral)
- Luliconazole Cream 1% - 2 wks
- BMS-770767
- Enfuvirtide-intensified HAART
- Fluvastatin
- Antithymocyte globulin (Rabbit)
- Octreotide
- Trastuzumab
- Bevacizumab standard of care
- Leucovorin
- AZD7325
- Background regimen (BR) for MDR-TB (multi-drug resistant tuberculosis)
- View Full List
CROs by country
- Contract Research Organizations in Albania
- Contract Research Organizations in Angola
- Contract Research Organizations in Canada
- Contract Research Organizations in Greece
- Contract Research Organizations in Kosovo
- Contract Research Organizations in Mali
- Contract Research Organizations in Moldova
- Contract Research Organizations in Nigeria
- Contract Research Organizations in Slovenia
- Contract Research Organizations in Sweden
- Contract Research Organizations in Taiwan
- Contract Research Organizations in Togo
- Contract Research Organizations in Ukraine
- CRO list by country